SEC Filing Summary for Boundless Bio, Inc.

Jonathan E. Lim, a director at Boundless Bio, Inc. (BOLD), acquired 48,000 stock options on June 15, 2026. These options, with an exercise price of $1.40, are set to expire on June 14, 2036. The options will vest over 12 months following the grant date, subject to Mr. Lim’s continued service on the board. The filing indicates these are direct holdings and are part of a Form 4 filing.